Study finds thousands of food-contact chemicals in humans, raising safety concerns

A recent study reveals that 25% of known food-contact chemicals (FCCs) are present in humans, with significant gaps in hazard data for many chemicals, highlighting potential health risks.

Cognition Therapeutics’ stock sinks on Phase 2 Alzheimer’s data

New Alzheimer’s data from Cognition Therapeutics appeared to show an early drug effect, but one that lessened over time. Cognition presented Phase 2 results from

July 30, 2024

atai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference | Psychedelic Invest

NEW YORK and BERLIN, May 23, 2024 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment

June 26, 2024

Can living in flood-prone areas increase your risk of death?

The long-term effects of flooding on mortality.

May 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.